SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-245522
Filing Date
2010-11-03
Accepted
2010-11-03 10:13:51
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d10q.htm 10-Q 306529
2 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY dex101.htm EX-10.1 8263
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9759
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9985
5 CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 5274
  Complete submission text file 0001193125-10-245522.txt   1666962

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mygn-20100930.xml EX-101.INS 198788
7 XBRL TAXONOMY EXTENSION SCHEMA mygn-20100930.xsd EX-101.SCH 10307
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20100930_cal.xml EX-101.CAL 33423
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20100930_lab.xml EX-101.LAB 107138
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20100930_pre.xml EX-101.PRE 69044
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 101160247
SIC: 2835 In Vitro & In Vivo Diagnostic Substances